“We carry on to work to a remaining list of telemedicine regulations,” a DEA spokesperson wrote in an electronic mail."DEA decided the proposed APQs for amphetamine, lisdexamfetamine and methylphenidate are adequate to supply legitimate health-related requirements, reserve stocks, and export requirements for 2024," the company wrote inside of a